Liminal BioSciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Liminal BioSciences generated cash of -$31,820,000, which is more than the previous year. Cash used in financing activities reached the amount of -$45,446,000 last year. Net change in cash is therefore -$71,346,000.
Cash Flow
| 2013 | -17.07M | -7.55M | 41.05M |
|---|---|---|---|
| 2014 | -25.95M | -8.74M | 44.34M |
| 2015 | -45.64M | -7.42M | 54.80M |
| 2016 | -97.69M | 9.9M | 86.93M |
| 2017 | -122.57M | 1.11M | 117.45M |
| 2018 | -82.45M | -5.85M | 72.15M |
| 2019 | -99.39M | 36.09M | 117.91M |
| 2020 | -75.91M | 2.30M | 57.40M |
| 2021 | -99.60M | 170.69M | -8.42M |
| 2022 | -31.82M | 3.81M | -45.44M |
LMNL Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 108.49M | 45.07M | 61.28M | 7.38M | 23.16M | 27.80M | 29.28M | 27.10M | 17.39M | 1.20M |
Operating activities | ||||||||||
Net income | 622K | 12.21M | -118.75M | -206.75M | -237.89M | -120.03M | -110.66M | -56.78M | 2.57M | -17.39M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 1.12M | 4.34M | 8.44M | 9.90M | 5.45M | 4.57M | 3.25M | 2.43M | 1.69M | 869K |
Stock-based compensation expense | 1.86M | 4.23M | 6.19M | 21.60M | 6.72M | 8.66M | 6.86M | 2.97M | 5.13M | 3.41M |
| Deferred income tax benefit | 1.86M | 4.23M | 6.19M | 21.60M | 6.72M | 8.66M | 6.86M | 2.97M | 5.13M | 3.41M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -31.82M | -99.60M | -75.91M | -99.39M | -82.45M | -122.57M | -97.69M | -45.64M | -25.95M | -17.07M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | -955K | 0 | -1.07M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -19K | -463K | -2.04M | -4.44M | -5.12M | -10.08M | -15.53M | -6.92M | -9.02M | -7.64M |
Acquisitions Net | 0 | 173.35M | 4.55M | 43.95M | -955K | 0 | 13.49M | -841K | 0 | 0 |
Cash generated by investing activities | 3.81M | 170.69M | 2.30M | 36.09M | -5.85M | 1.11M | 9.9M | -7.42M | -8.74M | -7.55M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 39.96M | 118.78M | 751K | 53.12M | 60.19M | 57.55M | 28.84M | 33.89M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -3.24M | -7.23M | 0 | -3.42M | 0 | 0 | 0 | -3.56M | -3.33M |
Cash used in financing activities | -45.44M | -8.42M | 57.40M | 117.91M | 72.15M | 117.45M | 86.93M | 54.80M | 44.34M | 41.05M |
Net Change In Cash | -71.34M | 63.41M | -16.21M | 53.89M | -15.77M | -4.64M | -1.47M | 2.18M | 9.70M | 16.19M |
Cash at end of period | 37.14M | 108.49M | 45.07M | 61.28M | 7.38M | 23.16M | 27.80M | 29.28M | 27.10M | 17.39M |
| Data source | Data source | Data source | Data source |